EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence, Molecular Landscape, and Clinical Impact of DICER1 and DGCR8 Mutated Follicular-Patterned Thyroid Nodules

Vincenzo Condello iD, Anello M Poma iD, Elisabetta Macerola iD, Paola Vignali, Johan O Paulsson iD, Jan Zedenius iD, Fulvio Basolo iD, C Christofer Juhlin iD

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgae034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Vincenzo Condello und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology-Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden. Hauptthemen laut MEDLINE: Ribonuclease III, DEAD-box RNA Helicases, Mutation, RNA-Binding Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Swedish Cancer Society, Wellcome Trust, Cancer Research Funds of Radiumhemmet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mutations in micro-RNA (miRNA) regulators DICER1 and DGCR8 have recently been uncovered, revealing a potential novel mechanism driving thyroid tumor development. However, the true frequency of these hotspot mutations in follicular-patterned thyroid tumors (FTs) and their relation to established driver gene events remain elusive.

Methods

A total of 440 FTs from 2 institutions were interrogated for DICER1, DGCR8, and RAS family hotspot mutations using Sanger sequencing. Whole-exome sequencing was also performed to identify additional driver gene aberrations in DICER1/DGCR8-mutant cases. Subsets of cases were further analyzed using miRNA expression profiling, and key dysregulated miRNAs were validated as markers of DICER1 mutations using quantitative RT-PCR analysis. The Cancer Genome Atlas (TCGA) database was also probed for DICER1/DGCR8 mutations and miRNA dysregulation.

Results

Fourteen (3.2%) and 4 (1%) FTs harbored DICER1 and DGCR8 hotspot mutations, respectively, in the combined cohort, and no cases with normal tissue available were found to exhibit a constitutional variant. Two DGCR8-mutant cases also harbored oncogenic RAS mutations. Whole-exome sequencing analysis did not identify additional driver gene events in DICER1/DGCR8-positive cases. Comprehensive miRNA expression profiling revealed a unique pattern of dysregulated miRNAs in DICER1/DGCR8-mutant cases compared with wild-type lesions. Moreover, DICER1-mutant cases showed a remarkable reduction of 5′ arm miRNAs, findings corroborated in the TCGA cohort.

Conclusion

DICER1 and DGCR8 hotspot mutations are rare in unselected cohorts of FTs, and mutated cases exhibit a specific miRNA profile. Although DGCR8 mutations may coexist with established RAS gene alterations, FTs with DICER1 variants were devoid of other driver gene events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ribonuclease IIIDEAD-box RNA HelicasesMutationRNA-Binding ProteinsMicroRNAsThyroid NoduleHumansFemaleMaleMiddle AgedAdultThyroid NeoplasmsAgedAdenocarcinoma, FollicularPrevalenceExome SequencingGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

DGCR8DICER1miRNAthyroid nodules

Substanzen

Ribonuclease IIIDICER1 protein, humanDGCR8 protein, humanDEAD-box RNA HelicasesRNA-Binding ProteinsMicroRNAs

Autor:innen und Institutionen

  • Department of Oncology-Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden.
  • Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, 56126 Pisa, Italy.
  • Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 64 Stockholm, Sweden.
  • Department of Breast, Endocrine Tumors, and Sarcoma, Karolinska University Hospital, 171 64 Stockholm, Sweden.
  • Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, 171 64 Stockholm, Sweden.

ORCID-Profile: Vincenzo Condello, Anello M Poma, Elisabetta Macerola, Johan O Paulsson, Jan Zedenius, Fulvio Basolo, C Christofer Juhlin

Förderung

  • The Swedish Cancer Society
  • Wellcome Trust
  • Cancer Research Funds of Radiumhemmet

Zitieren

APA

Condello, V., Poma, A. M., Macerola, E., Vignali, P., Paulsson, J. O., Zedenius, J., Basolo, F., & Juhlin, C. C. (2024). Prevalence, Molecular Landscape, and Clinical Impact of DICER1 and DGCR8 Mutated Follicular-Patterned Thyroid Nodules. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae034

Vancouver

Condello V, Poma AM, Macerola E, Vignali P, Paulsson JO, Zedenius J, et al. Prevalence, Molecular Landscape, and Clinical Impact of DICER1 and DGCR8 Mutated Follicular-Patterned Thyroid Nodules. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae034

BibTeX
@article{Condello2024,
  author = {Condello, Vincenzo and Poma, Anello M and Macerola, Elisabetta and Vignali, Paola and Paulsson, Johan O and Zedenius, Jan and Basolo, Fulvio and Juhlin, C Christofer},
  title = {Prevalence, Molecular Landscape, and Clinical Impact of DICER1 and DGCR8 Mutated Follicular-Patterned Thyroid Nodules},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgae034}
}
Kostenlos starten →